Prof. Xiaoming Yang has served as the Chairman of the Board at CNBG since March 2015. He oversees the corporate strategy, governs the high-level operations, and integrates internal and external resources to promote the organic growth and expansion of the company. Before assuming his current position, he held several senior positions in Sinopharm, including the Chief Engineer of Sinopharm, the President of the CNBG, and the General Manager of WIBP. He serves as a member of the leadership team in several leading organizations and programs, including Chief Scientist of the Vaccine Project in the National 863 program, General Director of the National Combo Vaccine Engineering Technology Center, Vice-Chairman of the Vaccine Committee of Chinese Pharmacopoeia Commission (ChPC), Executive Director of the Chinese Society of Immunology, Member of the Joint Prevention and Control Mechanism of the State Council-Vaccine Research Committee, Chairman of Board of Biologicals at Chinese Preventive Medicine Association, Vice President of China Medicinal Biotechnology Association, and member of the Vaccine committee.